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Abstract
Breast cancer has been reported to account for the maximum cases among all female cancers
till date. In order to gain a deeper insight into the complexities of the disease, we analyze the
breast cancer network and its normal counterpart at the proteomic level. While the short range
correlations in the eigenvalues exhibiting universality provide an evidence towards the impor-
tance of random connections in the underlying networks, the long range correlations along with
the localization properties reveal insightful structural patterns involving functionally important
proteins. The analysis provides a benchmark for designing drugs which can target a subgraph
instead of individual proteins.
One of the major goals of the post-genomic era is to understand the role of proteomics and
genomics in human health and diseases [1]. The world health organization has estimated that about
11 percent of the total cancers accounts for breast cancer and a drop of about one-third of the cancer
deaths could be attained if detected and treated early [2]. Molecular studies and healthcare research
has shown that the detection of more and more genes after BRCA1 and BRCA2 implicative in breast
cancer has rendered research, diagnosis and treatment strategies more ambiguous as the dangers being
posed by those genes are yet uncertain [3]. Complexity as well as variations at every stage of the cancer
render designing drug targets very difficult [4,5]. The ample availability of data in functional genomic
and proteomic information and the development of high-throughput data-collection techniques has
resulted from basic gene-based traditional molecular biology to a systems approach of network biology
[6, 7]. In this approach, biological processes are considered as complex networks of interactions
between numerous components of the cell rather than as independent interactions involving only
a few molecules [8–10]. Previous attempts to understand various diseases under network biology
approach reveals that various types of cancers are interlinked to each other through some pathways
which are altered in different diseases [11]. Further analysis of the centrosome dysfunction under
the network theory framework demonstrates importance of hub proteins as well as those connected
with them [12, 13]. This paper, in order to achieve a deeper understanding of the complexity of
breast cancer, its interacting patterns, role and importance of interaction patterns for the disease,
analyzes protein protein interaction (PPI) network using a novel mathematical tool random matrix
theory (RMT). This technique is known to develop fifty years back to explain interactions of complex
nucleons [14], has recently exhibited its remarkable success in understanding complex systems arising
from diverse fields ranging from quantum chaos to galaxy [15]. While structural parameters namely
degree, clustering coefficient (CC), degree clustering correlation and diameter demonstrate similarities
in both the normal and disease networks, the structural patterns such as cliques combined with
proteins revealed through the spectral analysis indicate changes in both the networks, which might
be important behind transformation of a cell from the normal to the disease state. The present
work not only straightens the importance of structural patterns in the disease, further demonstrating
the success of the network framework, but also for the first time analyzes a disease using the RMT
techniques. This combined framework helps in detecting proteins, beyond their structural significance
in the underlying network, which are crucial for the disease. A detailed analysis of the top contributing
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nodes (TCNs) in the localized eigenvectors reveal their importance in the occurrence of the disease
state.
Results and discussions
Structural properties of cancer networks
The structural parameters of the largest connected cluster of the network using dataset described in
the materials and methods section, are summarized in the Table. 1. The degree distribution ρ(k)
Network N NLCC NCLCC 〈k〉 D 〈CC〉 NCC 〈IPR〉
Normal 2464 2441 15118 12 11 0.28 153 0.004
Disease 2096 2046 14150 14 10 0.29 107 0.005
Table 1: Network parameters for both the normal and disease networks.The total number of
proteins N collected using various databases (described in the Method section), number of proteins
in the largest connected cluster NLCC and connections NCLCC , the average degree 〈k〉, average
clustering coefficient 〈CC〉, the number of nodes having CC = 1 in the whole network (NCC) and
the average IPR of both the networks.
of both the networks follow the power law (Figure-1) indicating the presence of very high degree
nodes. These nodes are known to keep the network robust against random external perturbations,
as well as have been found to be functionally important in many pathways [16]. The degree and
CC of the normal and the disease networks are negatively correlated (Figure-1), as found in the
case of other biological systems [17]. As mentioned in the Table. 1, the average CC of both the
networks is high as exhibited by most of the biological systems investigated under network theory
framework indicating presence of functional modules [10]. What follows that the disease and normal
networks exhibit overall similar statistics for widely investigated structural properties but the crucial
differences between them which are of potential importance, are revealed through the analysis of
cliques structures and spectra. As reflected in Table. 1, the disease network bears less number of
nodes with CC = 1 than the normal one. The value of CC for a node being one reflects the formation
of complete subgraph or clique comprising of that node. The higher value of average CC implicates
the presence of high number of clique structure in a network [18]. Further, cliques are known as
building blocks of a network for making the underlying system more robust [19] and stable [20].
Additionally nodes forming cliques structure are known to be preserved during evolution [21]. What
follows that the disease network having less cliques of order three as well as less number of nodes
with CC being one as compared to the normal one indicate that there is a demolition of building
blocks in the disease state, which may be leading to a more unstable underlying system, and might
be one of the reasons behind occurrence of the disease.
The importance of clique structures would become more clear after we explain spectral properties
and local patterns of top contributing nodes (TCNs) appearing in the spectral analysis performed
under the powerful framework of RMT. This analysis not only reveals functionally important proteins
but also helps in uncovering importance of structural pattern in the disease network. In the following,
we provide the results pertaining to the global spectral properties, eigenvalue fluctuations and prop-
erties of nodes appearing in the localized eigenvectors. These are the most frequently used techniques
in RMT for analysis of spectral properties in order to achieve a comprehensive understanding of the
underlying complex system.
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Figure 1: Degree distribution and degree-CC correlations for the normal and disease
networks. Left panel of the normal network show that the degree distribution follows power law
and the degree clustering coefficient correlation shows are negatively correlated. The right panel
gives us the same results for the disease networks.
Universality and the deviation from the same
The eigenvalue statistics reflects typical triangular shape with the tail of the distribution (Figure-
2) relating with the exponent of the power law of degree distribution as observed for many other
biological and real world networks [22, 23]. Both the disease and normal networks have about 30%
eigenstates with zero eigenvalues. This high degeneracy at zero is not surprising as many of the
biological networks have been shown to yield very high degeneracy at zero [22]. Further, as depicted
in Figure-3, both the disease and normal networks follow GOE statistics of random matrix theory
at the consecutive eigenvalues captured through the distribution of their ratio (Eq. 4), which reflects
that both the networks have a minimal amount of randomness [22]. Randomness in a network
might be arising due to some nonsense mutations [24] occurring in the underlying system. We
remark that in dynamical systems, randomness may be related with the unpredictable nature of
time evolution (for example: chaotic systems) [25], whereas for networks, randomness is referred
to as random connections between nodes [26], which for biological systems might have evinced in
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Figure 2: Eigenvalue distribution of both normal and disease networks. The plots depict
triangular distribution for both the networks with a high degeneracy at zero.
the course of evolution randomly and not because of any particular functional importance of that
connection. For instance, emergence of the modular structure in networks, which are known to
be motivated by their specific functional role in the evolution [27] might be linked with random
connections perhaps resulting from mutations [24]. Further, randomness in the interactions has been
known to be important for functioning of the underlying system. For instance, information processing
in the brain is considered to arise because of many random long-range connections among different
modules [28] making the underlying system robust [19]. (Supplementary material contains details
about RMT technique). The universal Gaussian orthogonal ensemble (GOE) statistics displayed by
the disease network on one hand, indicates the robustness of the cell even in the disease state, which
may be considered crucial for maintenance and housekeeping processes of cancerous cell and on other
hand establishes that the breast cell can be modeled using GOE of RMT and we can apply all the
techniques developed under the well established framework of the RMT to understand the breast
cancer.
After the short range correlations, which is analyzed through probability of ratio of consecutive
level, the second most insightful step in the RMT is the analysis of long range correlations in eigen-
value using spectral rigidity test, which is generally done using ∆3 statistics given by Eq. 5. This
test reveals that both the networks follow RMT prediction of GOE statistics till a particular value
of L (Eq.6) and deviates thereafter. Interestingly, the value of L for the disease network is less as
compared to the normal one (Figure-4), suggesting that the normal network is more random than the
disease network [26] or the disease network is more ordered than the normal one. This interpretation
combined with the observation that the disease state has a less number of connections (pathways
expressed) than that of the normal one, implicates that there are some interactions getting ham-
pered or silenced during the course of mutation leading to the disease [11]. What follows that, these
hampered pathways should be corresponding to or treated as random pathways and as randomness
is one of the essential ingredient for the robustness of a cell [26], lack of sufficient randomness might
be leading to the disease.
While universal part following RMT prediction reflects the importance of random connections in
the biological networks, we will witness in the following that the non-universal part of the spectra
deviating from RMT provides direct clue about the set of nodes (proteins) relevant for the occurrence
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Figure 3: Spacing distribution. The ratio of eigenvalues spacing follow GOE statistics for both
the networks. The bars represent data points and solid line represents Eq.4 with parameters of GOE
statistics.
of the disease state. This is achieved by analyzing localization properties of eigenstates which provides
a quantitative picture of non universal part of the spectra.
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Figure 4: Long-range Correlations (∆3 statistics) for the normal and the disease network.
Circles denote data points for the normal and the disease networks whereas the solid line is the ∆3
statistics for the GOE.
Important proteins through eigenvector localization
Based on the IPR values calculated using Eq.7, the eigenstates can be divided into two components,
one which follows RMT predictions of Porter-Thomas distribution [29], and another one which devi-
ates from this universality and show localization (Figure-5).
The average IPR calculated using Eq.8 comes out to be more for the disease network than for the
normal one, which is in the direct relation with the behavior of ∆3 statistics demonstrating that the
normal network is more random than the disease network. The part of the unfolded spectra following
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Figure 5: Eigenvector Localization both normal and disease network. They clearly reflect
three regions (i) degenerate part in the middle, (ii) a large non-degenerate part which follow GOE
statistics of RMT and non-degenerate part at both the end and near to the zero eigenvalues which
deviate from RMT.
universality corresponds to random interactions in the underlying system [30], whereas non-universal
part can be exploited to get the system dependent information. The non universal part annotating
the importance of the localized eigenvectors reveals important proteins as explained below. The
disease network yields 34 TCNs corresponding to the top 5 most localized eigenvectors extracted
by taking the threshold as 1/IPR [31], of which 18 appears to be unique in the disease and 14 are
common to both the disease and the normal networks. In the following section, we discuss briefly
the functions of these proteins selected through the localization property of eigenvectors (Table. 2).
Ek TCN k CC
714 MTHFD1L, ALDH1L1,
CACNB1, CACNB2, KCNB2
2, 2, 3, 3, 5 1, 1, 0.66,
0.66, 1
704 KCNB2, KCNH4, TEX1,
CACNB2, KIAA1, THOC1
5, 5, 6, 3,
3, 3
1, 1, 1, 1,
1, 1
712 KLK5, KLK10, CNTN4, ASTN2,
BRMS1L, ARID4B, KCNQ5
3, 3, 2, 2,
3, 3, 5
1, 1, 1, 1,
1, 1, 1
710 THOC1, BRMS1L, KCND3,
KCNB2, KCNQ5, ARID4B,
TEX1, KCNH4
6, 3, 5, 5,
5, 6, 5, 3
1, 1, 1, 1,
1, 1, 1, 1
705 KCND3, FCRL3, FCRL5, TEX1,
THOC6, KCNH4, KCNQ5,
MTFHD1L
5, 2, 2, 6,
6, 5, 5, 2
1, 1, 1, 1,
1, 1, 1, 1
Table 2: Eigenvector localization properties.Top most localized eigenvectors (Ek) for the dis-
ease dataset, their top contributing proteins and network parameters namely degree and clustering
coefficient. The betweenness centrality of all the TCNs in the disease network is zero.
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Functional properties of disease proteins
The most important outcome of the functional analysis of proteins corresponding to the TCNs is
that all of them are involved in important pathways leading to breast cancer. The first localized
eigenvector has five contributing nodes, of which MTHFD1L is responsible for synthesis of purines in
mitochondria but its expression is up-regulated in breast cancer leading to proliferation, invasiveness
and anti-apoptotic activity [32]. The protein corresponding to the next TCN is ALDH1L1 which in
the normal cell controls the cell mobility, but in the disease state is silenced thereby making way for
uncontrolled proliferation of cells [33]. The next two proteins CACNB1 and CACNB2 help in calcium
transport in the normal state but are down-regulated in the breast cancer cell, thereby affecting the
calcium metabolism which causes poor signaling of messages in the cell [34]. Mutation in the last
TCN KCNB2, results in concomitant cell proliferation [35].
The second localized eigenvector consists of six TCNs, among which KCNB2 and CACNB2 have
been discussed above. The third protein KCNH4 in a normal cell is responsible for the potassium
transport but undergoes splicing and is silenced in the disease state, thereby hampering early event in
apoptosis leading to prolonged survival of cells [36]. The next protein TEX1, under normal condition,
plays a major role in transcription regulation, but in the breast cancer cells, is over expressed which
causes down-regulation of transcription [37]. The next TCN, KIAA1, is a binding protein to RNA
but in cancer state undergoes mutation and refrains from its function of binding to RNA resulting in
hampering of proper translation in cancer [38]. The next protein THOC1 is a part of TREX complex
which is responsible for regulating transcription in a normal cell but in breast cancer cell, it delays
transcriptional expression leading to irregular central dogma which makes the cell unorganized [37].
There are seven TCNs in third most localized eigenvector. The first two proteins, KLK5 and
KLK10, are from Kellikein gene family which are generally involved in serine-type peptidase activi-
ties. In the breast cancer they are down-regulated leading to the suppression of tumorigenesis [39].
The next protein CNTN4 is implicated in nervous system development. As of now its exact function
in breast cancer is not known, but its first interacting neighbor is BRCA1 which is potent candidate
in breast cancer cells [40]. Similarly, the next contributing node, ASTN2, under normal condition
controls neural migration but in the breast cancer is found to have undergone chromosomal rear-
rangement with PTPRG which is an important gene for the recognition of the cancerous state in the
cell [41]. The next protein, BRMS1L, is found to reduce expression of mRNA in breast cancer [42].
Another protein, ARID4B, functions in diverse cellular processes including proliferation, differenti-
ation, apoptosis, oncogenesis, and cell fate determination. In the disease state, it is found to cause
irregular cell formation and proliferation [43]. KCNQ5 is another TCN which is a family member of
KCN which affects the cell proliferation of the breast cell [35].
The fourth localized eigenvector has eight TCNs of which KCND3 elevates the influx of potassium
ions in breast cancer cells [44]. The others appear in the three most localized eigenvector and have
been already discussed. Among the top contribution nodes of the fifth localized eigenvector, except
THOC6, FCRL3 and FCRL5, all other have been discussed above in different localized vector. These
three proteins have been found in both normal and breast cell. THOC6, in normal cell accounts for
negative regulation of apoptosis, whereas in the breast cancer cell have been found to be silenced [37].
Next two proteins FCRL3 and FCRL5 appear as a part of FCRL complex which under normal
circumstances act as an adapter of protein as well as development in immunity. In breast cancer,
they have been found to be over expressed in immune cells namely WBC, thereby making it more
robust against treatments [45].
What follows that all the proteins corresponding to the TCNs, except few, in the five most
localized eigenvectors have a major contribution in promoting breast cancer. Moreover, fourteen
common proteins are important for the normal and the disease both but leading to a very different
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behavior of cell in the two states. Whereas for normal cell, these common proteins are involved in
major functioning of the cell (Supplementary), in the disease cell they all are found to be abnormally
expressed or mutated leading to the disease state.
Preserved structures in localized nodes
The TCNs, in addition to the functional importance pertaining to the occurrence of the disease state
revealed, exhibits interesting structural properties. This is more remarkable in the light that all of
these TCNs lie in the low degree regime in the networks. Moreover, their betweenness centrality also
are zero further ruling out any trivial structural significance of these nodes. But importance of these
nodes based on the analysis of their interactions reveals the existence of preserved local structural
patterns. Most strikingly, all of them follow phenomenon of gene duplication [46], as depicted in the
Figure-6, which shows TCNs being involved in the pair formation in which first node in each pair has
exactly the same neighbors as of the second node. Most remarkably, there are 20 duplicates (proteins
having the same number of neighbors and having more than one connection) in the whole network
of which 18 are found in the TCNs of the most localized eigenvectors.
Further insight to this local structure is surfaced when we analyze the interaction patterns of these
proteins in the normal breast network. What comes out from the analysis of the local interaction
patterns of TCNs in the normal to those of disease is that there is either addition(s) of new interaction
in the disease state in order to build clique of order three, or preservation of clique structure from
normal to the disease or removal of interactions while in the normal keeping the clique intact. For
example, TEX1 and THOC6, retain the same clique structures in both the networks (Figure-6). There
are other proteins, for example BRMS1L and ARID4B which shed off some connections from the
normal network (Figure-6(right)) while keeping clique structure intact in the disease state (Figure-
6(left)). Further, nodes KLK5 and KCND3 form new connection in the disease state yielding the
clique structures (Figure-6(left)). The fact that in spite of less connections of the proteins in the
disease state as compared to the normal as well as reduction of cliques of order three from the normal
to the disease, cliques in TCNs are preserved. This may be one of the reason of the poor performance
of drugs targeting these proteins, as cliques are known to be the building blocks of a system making
the underlying system robust against external perturbations. While the less number of nodes with
CC = 1 as well as less number of clique of order three in the overall disease network from the normal
one implicate that there is a destruction of building block, the conservation or addition of cliques
of order three in TCNs (whose function importance for the occurrence of disease has already been
emphasized) reflects that mutation in the disease cell makes the proteins to form a stable structure.
Conclusions
We construct and investigate the breast cancer network under the RMT framework. The analysis
reveals that the TCNs of the most localized eigenvectors, despite of lying at low degree regime and
having zero betweenness centrality, exhibit structural significance. All of them form pairs possessing
common neighbors. Most remarkably, in the disease network there are 20 duplicate proteins with
connections more than one, and out of which 18 appear in the localized eigenvector. This interesting
revelation turns out to be more intriguing in the light of the functional analysis of proteins corre-
sponding to the TCNs which clearly confirms their functional importance for the occurrence of the
disease state.
Furthermore, clique structure and duplication of genes, which have been emphasized important
for robustness as well as the evolution of a system, are found to be crucial for the disease state.
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Figure 6: Local structure of top contributing nodes. (Left panel) The local structure of all
TCNs in the disease network. (Right panel) The local structure for the same proteins in the normal
network. Yellow represents TCNs and pink represent their first neighbor.
Most striking revelation is that while there is an overall reduction in cliques in the disease network
from the normal one reflecting reduction in the building blocks for the disease state, conservation or
formation of cliques involving important disease proteins reflects that robustness of the overall system
is decreased in the disease but the interactions of the important proteins involved in promoting the
disease are preserved and might be one of the reasons behind making those pathways involved with
the important proteins highly resistant to various treatments.
The ∆3 statistics demonstrates less randomness in the disease state than the normal one, which
might be arising due to the removal of random connections in the disease state, and not because of
a probable enhancement in the modular structure as number of nodes having CC = 1 is indeed less
in case of the disease state than the normal one. This in-turn depicts that randomness leads to the
robustness of the system where, normal breast network is found to be more robust than the disease
state.
Detection of important proteins involved in breast cancer using RMT platform provides a time ef-
ficient and cost effective approach for those diseases which lack in-depth information about important
genes. Revelation of clique structure, being formed or preserved by these proteins, provides a further
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bench mark for designing drugs which can target a sub-graph instead of the individual protein. This
analysis presented here can be extended further to study other diseases like other types of cancers,
diabetes, hypertension etc to predict various structural and functional aspect of biology [47], which
in addition may help to compose novel drug targets and to introduce the concept of single medicine
for multiple diseases [48].
Methods
Data assimilation and network construction
According to the network theory, there are two basic components of network namely nodes and edges.
Here we study the PPI network where nodes are the proteins and edges denote the interactions. After
diligent and enormous efforts, we collect the protein interaction data from various literature and
bioinformatic sources. To keep the authenticity of the data we only take the proteins into account
which are reviewed and cited. We use various different bioinformatic databases namely Gen bank
from NCBI and UNIPROT [49, 50], constituting data available from other resources like European
Bioinformatic Institute, the Swiss Institute of Bioinformatics, and the Protein Information Resource.
To add more information we also take the most widely studied normal and breast cancer cell lines
whose protein expression data is known. There are numerous cell lines available but a very few have
been exploited for their maximum proteomic insight. Here, we are use the data of HMEC cell line
for normal [51, 52] and MFC-7 for the breast cancer network [53]. The collection and discussion to
select the datasets and authenticating this data for RMT analysis is an extensive job and we generate
this data after thorough literature search and validation in about 400 hrs of rigorous study. After
collecting the proteins for both the datasets, their interacting partners are downloaded from STRING
database [54]. The dataset contains 2464 nodes and 15131 connections for normal network followed
by 2096 nodes and 14183 links for the breast cancer network. The networks turned to have one big
cluster and several small clusters. We then investigate the structural properties of the network.
Structural measures
Several statistical measures are proposed to understand specific features of the network [55]. First
we define the interaction matrix or the adjacency matrix of the network as follows:
Aij =
{
1 if i ∼ j
0 otherwise
(1)
The most basic structural parameter of a network is the degree of a node (ki), which is defined as the
number of neighbors of the node has (ki =
∑
j Aij). Degree distribution ρ(k), revealing the fraction of
vertices with the degree k, is known as the fingerprint of the network. Another important parameter
is the clustering coefficient (CC) of the network. Clustering is defined as the ratio of the number of
connections a particular node is having by the possible number of connections the particular node
can have. These are also known as cliques. Clustering coefficient of a network can be written as
CC =
1
n
n∑
i=1
Ci (2)
They are complete sub graphs in the network which are known to be the conserved part of the
network [21]. The average clustering coefficient of the network characterizes the overall tendency of
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nodes to form cluster or groups [55]. Further, the betweenness centrality of a node i is defined as the
fraction of shortest paths between node pairs that pass through the said node of interest [56]
xi =
∑
st
nist
gst
, (3)
where nist is the number of paths from s to t that passes through i and gst is the total number of
paths from s to t in the network. Another parameter is the diameter of the network which measures
the longest of the shortest path between the two nodes.
Spectral techniques
The random matrix analysis of the eigenvalue spectra considers (1) global properties such as spectral
distribution of eigenvalues ρ(λ), and (2) local properties such as eigenvalue fluctuations around ρ(λ).
We denote the eigenvalues of a network by λi = 1, . . . , N and λ1 > λ2 > λ3 > . . . > λN . The nearest
neighbor spacing distribution (NNSD) has been known to be one of the most powerful technique in
RMT and we analyze them by calculating the distribution of ratio of the consecutive eigenvalues
which is represented as [57]
PW (r) =
1
Zβ
(r + r2)β
(1 + r + r2)(1+3/2β)
(4)
The benefit of analyzing ratio of nearest spacings over much used NNSD [58] is that this method
does not require unfolding of the eigenvalues. Further, the NNSD accounts only for the short range
correlations in the eigenvalues. We probe for the long range correlations in eigenvalues using ∆3(L)
statistics which measures the least-square deviation of the spectral staircase function representing
average integrated eigenvalue density N(λ¯) from the best fitted straight line for a finite interval
of length L of the spectrum. In order to get the universal properties of eigenvalues through h ∆3
statistics, it is customary in RMT to unfold eigenvalues by a transformation λ¯i = N¯(λi), where N¯
is the average integrated eigenvalue density. Since we do not have any analytical form for N , we
numerically unfold the spectrum by polynomial curve fitting. After unfolding, average spacings are
unity, independent of the system,which in the absence of any analytical form of polynomial fitting of
the eigenvalues works with the approximate numerical fitting [58] and is given by
∆3(L; x) =
1
L
mina,b
∫ x+L
x
[N(λ)− aλ− b]2dλ (5)
where a and b are regression coefficients obtained after least square fit [58]. Average over several
choices of x gives the spectral rigidity, the ∆3(L). In case of GOE statistics, the ∆3(L) depends
logarithmically on L, i.e.
∆3(L) ∽
1
pi2
lnL (6)
Further, we use the inverse participation ratio (IPR) to analyze localization properties of the
eigenvectors [59]. For Ekl denoting lth component of kth eigenvector E
k, the IPR of an eigenvector
can be defined as
Ik =
∑N
l=1[E
k
l ]
4
(
∑N
l=1[E
k
l ]
2)2
(7)
which shows two limiting values : (i) a vector with identical components Ekl ≡ 1/
√
N has Ik = 1/N ,
whereas (ii) a vector, with one component Ek1 = 1 and the remainders zero, has I
k = 1. Thus, the
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IPR quantifies the reciprocal of the number of eigenvector components that contribute significantly.
We further calculate the average IPR in order to measure an overall localization of the network
calculated as [60],
〈IPR〉 =
∑N
l=1[I
k]
N
(8)
Note that IPR defined as above separates out the TCNs by keeping the threshold as 1/IPR.
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Supporting Information
Breast cancer being the highest among all the cancers is a potential field of research. We apply
RMT to understand the biological insights of the disease through network modeling. We construct
both the networks of which the unconnected cluster can be seen in the figure (SI Figure 1).
SI Figure 1: Normal (left panel) and disease (right panel) breast cancer network.
Short range correlations in Eigenvalues
The nearest and next-nearest spacing distribution (NNSD and nNNSD) account for the short range
correlations in the eigenvalues. We calculate the NNSD of normal and breast cancer network and
find that it follows random matrix predictions.
As mentioned in the main article, we denote the eigenvalues of a network by λi, i = 1, . . . , N ,
where N is size of the network and λ1 < λ2 < λ3 < · · · < λN . The density distribution ρ(λ) follows
semi-circular distribution for GOE statistics. For spacing distribution of eigenvalues, one needs to
unfold the eigenvalues by a transformation λi = N(λi), where N(λ) =
∫ λ
λmin
ρ(λ′) dλ′ is the averaged
integrated eigenvalue density [1]. In the absence of an analytical form for N , spectrum is unfolded
numerically by polynomial curve fitting and spacings are calculated as s
(i)
1 = λ¯i+1− λ¯i. In the case of
GOE statistics, the spacing distribution is given by P (s1) = (pi/2)s1 exp(−pis21/4) For intermediate
cases, the spacing distribution is described by Brody distribution as
Pβ(s1) = As
β exp
(
−αsβ+11
)
(SI 1)
where A = (1 + β)α and α = [Γ(β + 2/β + 1)]β+1. As β goes from 0 to 1, the Brody distribution
smoothly changes from Poisson to GOE. We find that the nearest neighbor spacing distribution
(NNSD) can be fitted using the Brody distribution (SI Eq.1) suggesting that the network can be
modeled using appropriate ensemble of RMT. Fitting with the Brody distribution yields the value
of β = 1, for both the networks indicating that the system lies close to the GOE (Fig. 2). The next
nearest spacing distribution (nNNSD) P (s2), where s2 = λ¯i+2− λ¯i, provides a fairly good fitting with
the NNSD of Gaussian symplectic ensemble (GSE), given by
P (s2) =
218
36pi3
s42 exp(− 649pis22)) (SI 2)
confirming further that the underlying systems can be modeled by using universal GOE class of
RMT (SI Figure 2).
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SI Figure 2: (Color online) (a,b) NNSD and (c,d) nNNSD. The histogram represents the numerical
result and the solid line (blue) is fitted by (a,b) Brody distribution given by SI Eq.1 and (c,d) NNSD
of GSE random matrices.
Functional properties of normal proteins
The top contributing node for the first localized eigen vector are as follows ATP13A1, LACTB,
ASTN2, CNTN4, TPD52L2, MAGEC2, MAGEA12, C17orf49, ALDOA, GABRA5, PTP4A1 respec-
tively which comes around eleven contributing nodes. The first top contributing node is ATP13A1,
which are transporters who are used to transport inorganic cations and other substrates through
cell membranes. LACTB major role is to promote intramitochondria membrane organization and
micro-compartmentalization, thereby giving power to cells. Both ASNT2 and CNTN4 are described
in separate section. TPD52L2 has major role is in alternate splicing and regulatory binding of pro-
teins in cell. MAGEC2, their role is in immune system as potential target antigen. MAGEA12 which
represent antigen in cytokines and T cell of lymphocytes. C17orf49 are basically open reading frame
for translation process in cell. ALDOA are enzyme associated with process of glycolysis. GABRA5
are used as inhibitory neurotransmitter in Central Nervous System. PTP4A1, major role is in cell
migration and growth.
The top contributing nodes for second most localized vector are MUCL1, GALNT5, TPD52L2,
FCRL5, FCLR3, DSG2, TMEM43, NEK8, PKHD1, TPD52, VAMP7 and USE1 respectively and
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comes around twelve contributing nodes. MUCL1 is coded for primary transcripts in normal breast
tissue. GALANT5 a part of N-acetylgalactosaminyl transferase,in normal cells serve as charge density
and maintenance of B-domain. TPD52L2 was present in first localized eigen vector and has been
discussed. FCRL3 and FCRL5 have been found in both disease and normal cells, hence they have been
discussed in different section.DSG2 helps in epithelial morphogenesis and cell positioning in normal
breast cell. TMEM43 act as enzyme protein in Wnt/Beta-catenin signal transduction pathway. NEK8
plays a major role in G2/M progression and promote centrosome maturation during mitosis. PKHD1
codes for multiple transcription protein domains. TPD52, they are part of D52 family whose primer
function has been the regulation of vesicle trafficking and exocytotic secretion. VAMP7 function
is lysosomal exocytosis in normal breast cell. USE1, function in the fusion of retrograde transport
vesicles.
The top contributing nodes for third most localized vector are JARID2, EHMT1, SLAMF8,
SLC7A7, SPG21, ZFYVE26, C17orf49, INO80C, MGST3, MGST1, TEX1 and THOC6 respectively.
JARID2 are responsible for transcriptional repression in normal breast cell. EHMT1, causes methyla-
tion of euchromatin in normal cells. SLAMF8, responsible for inflammatory reaction in normal cells.
SLC7A7, primer role is metabolism of protein, especially in arginine metabolic pathway. SPG21
current role is unknown but their interacting partner ALDH1, which is factor for cell growth, cell
differentiation and cell proliferation. ZFYVE26, are phosphate binding protein who are used to check
cytokinesis in cells.C17orf49, has been discussed in first localized eigen vector. INO80C, helps in re-
modelling transcription,replication and repairment.MGST1 and MGST3, are used to control mRNA
expression in normal cell.TEX1 and THOC6 are have been discussed in seperate section,since they
are present in both disease and normal cell.
The top contributing nodes for fourth most localized vector are JARID2, EHMT1, THOC6,
TEX1, ASTN2, CNTN4, TPD52L2, TPD52, SPG21, ZFYVE26, NEK8, PKHD1, SLC7A7, SLAMF8,
MGST3 respectively. JARID2 , EHMT1, SPG21, ZFYVE26, SLC7A7, SLAMF8, MGST3 have been
discussed in third most localized vector. THOC6, TEX1, ASTN2 and CNTN4 have been discussed
in another section. TPD52L2, TPD52, PKHD1, NEK8 have been discussed in second most localized
vector.
The top contributing nodes for fifth most localized vector are as follows MGST3, MGST1,
ATP13A1, LACTB, FCRL5, FCRL3, ASTN2, CNTN4, DOCK6, DOCK9, VAMP7, USE1, TPD52L2,
TPD52 and MAGEC2. FCRL5, FCRL3, ASTN2 and CNTN4 have been discussed in another sec-
tion. ATP13A1, LACTB, MAGEC2 and TPD52L2 have been discussed in first localized eigen vector.
VAMP7,USE1 and TPD52L2 have been discussed in second most localized eigen vector. MGST3
and MGST1 have been discussed in third localized eigen vector.DOCK6 is resposnsible for actin
cytoskeleton organization in cell.DOCK9 are GTPase activating protein.
Functional Properties of first neighbours :normal
The first neighbours normal are found to be GPX3, GSR, TUB, GSTP1, GSTK1, GSTZ1, GGT1,
ALDH1A3 are the first neighbour protein for ATP13A1, LACTB, MGST3 and MGST1. GSR also
called as human glutathione reductase has key role gluthione dependent antioxidant system ,recently
it has been found that, they are invovled in variation of expression in proteins.[2] TUB are those
protein whose function is considered as adaptor linking insulin receptors [3]. GSTP1 glutathione-
S-Transferase whose primer function is depended on glutathione but in recent time has been found
out that due to hypermethylation in GSTP1, they cause transcription silencing [4]. The kappa
class of Gluthione-S-Transferase have been associated with insluin secretion along with repression in
transcription, whenever hypermethylation occurs [5]. GSTZ1 Glutathione-S-transferase Zeta class
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are involved in enzymatic activity of glutathione transferase, but mutation in them causes functional
loss as well as silencing of transcription[6]. GGT1 is used as chemical markers for identifying tumour
[7]. All glutathione are used as enzymes which actively takes part in catalysis process, apart from that
mutation in them directly effects the transcription or translation process. ALDH1A3 has major role
in detoxification of aldehydes and lipids, apart from that they are used as markers in Stem cells for
the cure of breast cancer [8]. THOC4, THOC5, THOC7, THOC1, THOC2 are the first neighbouring
protein is TEX1 and THOC6. These are transcription complex which has a predominant role mRNA
transcription profiling and complex [9]. In normal cells their basic functioning includes mRNA export.
Next comes the proteins namely INO80C and C17orf49 which has KIAA1267, MAX, MCRS1,
LAS1L and HCFC1 as first neighbours. KIAA1267 along with C17orf49 are associated with chromo-
some 17 which is responsible for friendly behaviour, hypotonia and intellectual disability [10]. MAX
are specific proteins who are involved in recurring abnormalities in human tumour [11]. MCRS1
enable the antagonist to decrease the basal level of cAMP production, hence G receptor [12]. LAS1L
is nucloer protein who is required for cell proliferation and Ribosome Biogenesis [13]. HCFC1 is a
cellular factor which interacts with each protein to assemble the stable enhancer complex, in addition
to the function of house keeping genes [14]. PTP4A2, CDC42 and RAC1 are the first neighbour-
ing protein for PTP4A1, DOCK6 and DOCK9. PTP4A2 are used in development of placenta and
embroys[15]. CDC42 and RAC1 has major role in GTP binding of protein kinase pathway [16].
GALNT6 and MUC1 are the neighbours of FCRL3, FCRL5, MUCL1 and GALNT5. GALNT6 is
involved in fibronectin pathway which stabilises the development of fibronectin in breast cells [17],
whereas MUC1 when binds with cell adhesion molecules are responsible for the increase or decrease
in disease progression [18].
HDAC2, EZH2 and EED are the neighbours of JARID2 and EHMT1. HDAC2 and HDAC1 are
protein complex which along with E-cadherin promoter cause the repression in E-cadherin expression
and transcription regulation [19]. EZH2 controls DNA methylation. EED controls morphologic
movements during gastrulation in embryonic development [20]. MAGEA10, MAGEA4 and MAGEA1
are the neighbours of MAGEC2 AND MAGEA12. MAGEA10, MAGE4, MAGEA1 are member of
MAGE family, which are highly tumour specific [21]. Next we find that proteins namely, PKD2 and
NPHP3 are the neighbours of PKHD1 and NEK2. PKD2 are polycystin, which are bunch of large
glycoprotein that causes cell to cell adhesion and Plexin transcription promoter region [22]. NPHP3
are nephronophthisi group which code for nephrocystein protein [23]. DSP and PKP2are neighbours
of DSG2 and TMEM43 [24]. PKP2 have been implicated in cell cycle regulation and Ras signalling
through its interactions [25]. DSP are potential candidates for intracellular adhesion but due to
haplo-insufficiency mutation causes cardiomyopathy.
Further, GABRB2, GABRA4 and GABRA6 are found to be the neighbours of GABRA5. They
represent the family of gammaaminobutryic acid, hence they represent neurotransmitters [26]. SPAST
is the neighbour of SPG21 and ZFYVE26. Mutation in SPAST causes autosomal herditary mutation
[27]. SLCO2B1 is the neighbour of SLAMF8 and SLC7A7. Its basic function is anion tansporta-
tion of polypeptide [28]. HP and CDH10 are the first neighbour of CNTN4 and ASTN2. HP are
Haptoglobin complex along with haemoglobin undergo metabolism in reticuloendothelial system [29].
CDH10 are associated with neural cell adhesion molecules, it has been found out that single muta-
tion in mRNA expression causes autism spectrum disorder(ASD) [30]. STX5 is the first neighbour
of USE1 and VAMP7. STX is used for identifying the effects of nerve permiability during influx and
efflux of sodium ions in the body [31]. TPD52L1 is found to be neighbour of D52 family which are
responsible for regulating protein stability and transcription regulation[32,33]
Conclusion: Here we are able to find that most of the proteins which are in first neighbour to be
focussed on protein complexes and cell regulation whereas their parent are more focussed on house
keeping gene.In a way the technic is trying to reveal that the top contributing nodes or their first
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neighbours are involved in transcription complexes and regulation of cells (Cell growth proliferation
etc).
Functional Properties of first neighbours :disease
THOC4, THOC5, THOC2, THOC1 and THOC7 are the first neighbours of TEX1 and THOC6.
TEX1 and THOC are basically transcription complex,and these neighbours are found to be part
of it [34]. Therefore the major function is basically negative regulation of mRNA transcription,
but is silenced in breast cancer. KCNA5 and KCNA10 are found to be the first neighbours of
KCNB2, KCND3, KCNQ5 and KCNH4. The above mentioned are potassium gated ion channels,
major function being efflux and influx of potassium ions.In breast cancer the efflux of potassium is
exponentially high MUC1 has its first neighbors as FCRL3 and FCRL5 which are responsible for the
development in immunity, MUC1 to is overexpressed in breast cancer as immunoreceptor antigen.
They are considered as potential macrophage-restricted receptor. GART has neighbour namely
ALDH1L1 and MTHFD1L, former which cause uncontrolled proliferation in breast cancer and latter
causes differences in microRNA regulation. GART are responsible for brain development, but their
function in breast cancer are still not known.ASTN2 and CNTN4 are the neighbors of CDH10 where
ASNT2 undergoes chromosomal rearrangement with PTPRG, there by causing further mutation
in breast cells. CNTN4 plays an important role in neural development but CDH10 as their first
neighbour acts as transcription regulator in tumour or breast cancer. AKAP6 and CACNA1A are
neighbours for CACNB1 and CACNB2. AKAP6 are familial proteins who in breast cancer cause
extended proliferation of cells and uncontrolled growth. CACNA1A are calcium mediated channels
whose efflux decreases in breast cancer.
KLK7 and KLK8 from Kalkerin gene family, are downregulated in breast cancer. They are neigh-
bours for both KLK5 and KLK10 and encode serine protease enzyme which are preferentially down-
regulated.BRMS1L and ARID4B are the neighbours for BRMS1 and ARID4A repectively. ARID4A
and ARID4B are potential leukamania Suppressor gene. ARID4A and ARID4B act as adapters to
recruit mSin3A-histone deactylase to E2F dependent promoters, which are silent in breast cancer.
Both BRMS1L and BRMS1 are considered for the supression of metastasis.
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